Shelly R. Peyton

No ORCID on file · 4 papers in corpus · active 2016-2023

Study types

  • article 1
  • letter 1
letter 2023
Engineering the endometrium
·doi:10.1016/j.medj.2023.07.009
2022
Agent-based models help interpret patterns of clinical drug resistance by contextualizing competition between distinct drug failure modes
·doi:10.1101/2022.02.25.481999

Structured Abstract Introduction Modern targeted cancer therapies are carefully crafted small molecules. These exquisite technologies exhibit an astonishing diversity of failure modes (drug resistance mechanisms) in the clinic. This diver…

article 2022
Roadmap on biomaterials for women’s health
JPhys materials ·doi:10.1088/2515-7639/ac90ee

Abstract The application of engineering tools and techniques to studying women’s health, including biomaterials-based approaches, is a research field experiencing robust growth. Biomaterials are natural or synthetic materials used to repair…

2016
Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
The international journal of biochemistry & cell biology ·doi:10.1016/j.biocel.2016.08.030

Cathepsins are powerful proteases, once referred to as the lysosomal cysteine proteases, that have been implicated in breast cancer invasion and metastasis, but pharmaceutical inhibitors have suffered failures in clinical trials due to adve…